189 related articles for article (PubMed ID: 36523511)
41. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
42. PYCR1 regulates glutamine metabolism to construct an immunosuppressive microenvironment for the progression of clear cell renal cell carcinoma.
Wei X; Zhang X; Wang S; Wang Y; Ji C; Yao L; Song N
Am J Cancer Res; 2022; 12(8):3780-3798. PubMed ID: 36119844
[TBL] [Abstract][Full Text] [Related]
43. Identification of a m
Chen J; Yu K; Zhong G; Shen W
Cancer Cell Int; 2020; 20():157. PubMed ID: 32419773
[TBL] [Abstract][Full Text] [Related]
44. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
[TBL] [Abstract][Full Text] [Related]
45. N6-Methyladenosine-Related Long Non-coding RNA Signature Associated With Prognosis and Immunotherapeutic Efficacy of Clear-Cell Renal Cell Carcinoma.
Ma T; Wang X; Wang J; Liu X; Lai S; Zhang W; Meng L; Tian Z; Zhang Y
Front Genet; 2021; 12():726369. PubMed ID: 34721523
[TBL] [Abstract][Full Text] [Related]
46. Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma.
Zhang C; Li Z; Qi F; Hu X; Luo J
Ann Transl Med; 2019 Nov; 7(22):648. PubMed ID: 31930049
[TBL] [Abstract][Full Text] [Related]
47. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
[TBL] [Abstract][Full Text] [Related]
48. Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma.
Hu J; Wang T; Chen Q
Transl Cancer Res; 2019 Aug; 8(4):1046-1064. PubMed ID: 35116848
[TBL] [Abstract][Full Text] [Related]
49. Novel amino acid metabolism-related gene signature to predict prognosis in clear cell renal cell carcinoma.
Cheng X; Deng W; Zhang Z; Zeng Z; Liu Y; Zhou X; Zhang C; Wang G
Front Genet; 2022; 13():982162. PubMed ID: 36118874
[No Abstract] [Full Text] [Related]
50. Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma.
Xu S; Liu D; Chang T; Wen X; Ma S; Sun G; Wang L; Chen S; Xu Y; Zhang H
Front Genet; 2022; 13():938259. PubMed ID: 35910212
[No Abstract] [Full Text] [Related]
51. Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma.
Qiu Y; Wang X; Fan Z; Zhan S; Jiang X; Huang J
Immun Inflamm Dis; 2021 Dec; 9(4):1596-1612. PubMed ID: 34432955
[TBL] [Abstract][Full Text] [Related]
52. A prognostic nomogram based on competing endogenous RNA network for clear-cell renal cell carcinoma.
Peng Y; Wu S; Xu Z; Hou D; Li N; Zhang Z; Wang L; Wang H
Cancer Med; 2021 Aug; 10(16):5499-5512. PubMed ID: 34196116
[TBL] [Abstract][Full Text] [Related]
53. Systematic Investigation of Immune-Related lncRNA Landscape Reveals a Potential Long Non-Coding RNA Signature for Predicting Prognosis in Renal Cell Carcinoma.
Liu K; Li Z; Ruan D; Wang H; Wang W; Zhang G
Front Genet; 2022; 13():890641. PubMed ID: 35860468
[No Abstract] [Full Text] [Related]
54. Identification of a four immune-related genes signature based on an immunogenomic landscape analysis of clear cell renal cell carcinoma.
Gao X; Yang J; Chen Y
J Cell Physiol; 2020 Dec; 235(12):9834-9850. PubMed ID: 32452055
[TBL] [Abstract][Full Text] [Related]
55. Prognostic Value of Metabolism-Related Genes and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Li H; Mo Z
Int J Gen Med; 2021; 14():6885-6898. PubMed ID: 34703293
[TBL] [Abstract][Full Text] [Related]
56. Comprehensive Analysis of m
Wu J; Hou C; Wang Y; Wang Z; Li P; Wang Z
Int J Genomics; 2021; 2021():3803724. PubMed ID: 34631874
[TBL] [Abstract][Full Text] [Related]
57. A innovative prognostic symbol based on neutrophil extracellular traps (NETs)-related lncRNA signature in non-small-cell lung cancer.
Fang C; Liu F; Wang Y; Yuan S; Chen R; Qiu X; Qian X; Zhang X; Xiao Z; Wang Q; Fu B; Li Y
Aging (Albany NY); 2021 Jul; 13(13):17864-17879. PubMed ID: 34257164
[TBL] [Abstract][Full Text] [Related]
58. Identification of a Methylation-Regulating Genes Prognostic Signature to Predict the Prognosis and Aid Immunotherapy of Clear Cell Renal Cell Carcinoma.
Zhang L; Su Z; Hong F; Wang L
Front Cell Dev Biol; 2022; 10():832803. PubMed ID: 35309925
[TBL] [Abstract][Full Text] [Related]
59. Identification of a Necroptosis-Related Prognostic Signature and Associated Regulatory Axis in Liver Hepatocellular Carcinoma.
He A; Huang Z; Wang J; Lu H; Zhang R; Wu L; Feng Q
Dis Markers; 2022; 2022():3968303. PubMed ID: 35855852
[TBL] [Abstract][Full Text] [Related]
60. Integrated analysis of long noncoding RNA associated-competing endogenous RNA as prognostic biomarkers in clear cell renal carcinoma.
Yin H; Wang X; Zhang X; Wang Y; Zeng Y; Xiong Y; Li T; Lin R; Zhou Q; Ling H; Zhou F; Zhou Y
Cancer Sci; 2018 Oct; 109(10):3336-3349. PubMed ID: 30152187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]